INS and Hyperglycemia: Intriguingly, a significant genotype vs. lipid-treatment interaction with reduced glycogenolysis and less severe hyperglycemia was observed in Ala/Ala94 carriers [130], suggesting less impaired insulin signaling due to reduced hepatocellular uptake of lipotoxic FFA species.